EGFR and cancer: As H460 cells are EGFR wild-type cells, the results mean that the activation of phosphorylated proteins of AKT, ERK and JNK were existed in the cancer cells and suppressed by the combination agents, which might be responsible for the synergistic effect of HCPT and CRI on H460 cells.